Foghorn Therapeutics Inc
FHTX
Market Cap$433.22M
Close$
Share Statistics
| Market cap | $433.22 Million |
|---|---|
| Enterprise Value | $460.51 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.34 |
| Beta | 3.12 |
| Outstanding Shares | 51,580,310 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -4.67 |
|---|---|
| PEG | -14.03 |
| Price to Sales | - |
| Price to Book Ratio | -4.53 |
| Enterprise Value to Revenue | 18.05 |
| Enterprise Value to EBIT | -4.5 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.18 |
| Debt to Equity | -1.82 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Foghorn Therapeutics Inc
95 employeesFoghorn Therapeutics is pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untapped opportunity for therapeutic intervention. The ...